6CM
MBOT icon

683 Capital Management’s Microbot Medical MBOT Stock Holding History

683 Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-170,000
Closed -$410K – 205
2026
Q1 		$410K Sell
170,000
-86,033
-34% -$192K 0.02% 198
2025
Q4 		$512K Buy
+256,033
New +$606K 0.02% 193

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

683 Capital Management's MBOT Position: Q2 2026 in Review

683 Capital Management sold out of Microbot Medical (MBOT) in Q2 2026, closing a stake of 170,000 shares — an estimated $410K sold.

683 Capital Management first reported a position in MBOT in Q4 2025 and held it in 2 quarters. The position peaked at $512K in Q4 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • 683 Capital Management reported no remaining Microbot Medical position as of Q2 2026 after selling out during the quarter.
  • 683 Capital Management sold 170,000 Microbot Medical shares in Q2 2026, an estimated $410K.
  • 683 Capital Management first reported a position in Microbot Medical in Q4 2025 and held it in 2 quarters.
  • 683 Capital Management's Microbot Medical position peaked at $512K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.